(Q80339322)

English

Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care

scientific article published on 01 January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

schizoaffective disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ramy A Mahmoud

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Luella M Engelhart

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Carmela C Janagap

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gerry Oster

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dan Ollendorf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

275-286

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of newer antipsychotics on outcomes in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for drug-induced akathisia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unbalanced repeated-measures models with structured covariance matrices.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rehospitalization risk with second-generation and depot antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical research techniques in tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic mental patients: the quality of life issue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benzodiazepines in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring quality of life in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17503889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200424050-00004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503889%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80339322&oldid=2143701320"